Focus on sticking to the peak forever -- the enlightenment of Jianfeng Group's 60 years of entrepreneurship
Release time:
2020-07-31
Editor's Note: 11# March 20 , Jinhua Daily 1 edition published "Focus on Climbing the Peak Eternal-Enlightenment of Jianfeng Group's Entrepreneurship 60 " written by the reporter of the newspaper, which is specially reprinted by this newspaper.
Focus on Climbing to the Peak for All Times
-Enlightenment of Jianfeng Group's Entrepreneurship 60
Jinhua Daily Reporter Shao Xuilian
As of the end of the third quarter of this year, total assets 47.88 .5 billion yuan, net assets 33.66 .7 billion yuan, and net profit attributable to the parent company reached 4.88 .9 billion yuan, earnings per share 1.42 yuan. Recently, Jianfeng Group disclosed its beautiful third quarter report of 2018 , celebrating the 35th anniversary of its venture 60 with its best operating results in history.
60 years. With sustained and steady high-quality development, the peak people are moving towards a comprehensive modern enterprise group with strong core competitiveness.
, the first generation of peak people built the first cement factory in Jinhua history at the foot of peak mountain. 1983# Beginning in , through horizontal alliances with township enterprises, the formation of enterprise groups, and the implementation of shareholding reforms, Peak developed from a small state-owned cement plant to the first listed company in China's cement industry. Since then, in the stage of diversification, the peak will develop the pharmaceutical industry into the second pillar industry. 2007 , with the central enterprise China Building Materials, to participate in the formation of Southern Cement, the cement industry focus of strategic transfer; at the same time, through mergers and acquisitions, scientific and technological innovation, the pharmaceutical industry to further develop.
33 participating and holding subsidiaries, involving six major industries of building materials, medicine, health, modern logistics, international trade and communication cables. It is the earliest existing A listed company in our province. On the 63rd anniversary of
25#, Chairman Jiang Xiaomeng said that Jianfeng Group's continued stability benefits from its long-term strategic positioning of focusing on industry, which is the value orientation of Jianfeng and the responsibility of the enterprise. At the same time, it benefits from the combination of cyclical and non-cyclical dual-main business operating structure, and benefits from the core competitiveness formed in the long-term market competition. Cement is the foundation of the enterprise. Peak timely transfers the strategic focus of the cement industry to the areas along the national "the belt and road initiative", strengthens intelligent management and green production, and ensures excellent quality and profitability. As one of the "Top 50 Cement in China" and one of the
large enterprises with the state's key support for the structural adjustment of the cement industry, Spike Cement has established its position as a cost leader in the regional market, especially by virtue of its profitability per ton of cement, which ranks among the top in the industry. In the pharmaceutical sector, Jianfeng Group, on the one hand, has increased industrial mergers and acquisitions and improved the industrial chain. At present, Jianfeng Pharmaceutical has owned
wholly-owned, holding and participating pharmaceutical research and development and production enterprises. There are 3 pharmaceutical trading enterprises, which have established the production system of three major production bases of pharmaceutical intermediate raw materials, proprietary Chinese medicine preparations and chemical medicine preparations. On the other hand, intensify the development of new products, and form a research and development system with 1 provincial drug research institutes, 3 academician expert workstations, 4 postdoctoral workstations as the leading research and development institutions and four innovative drug development subjects. At present, it has 52 international and domestic patents, including 43 invention patents, ranking the top three in the market share of leading products, and increasing the research and development of anti-tumor drugs and infant drugs to become a technology leader in subdivided fields. Pattern: Open and Inclusive
The strategic transfer of cement industry is cooperation and integration. The sudden rise of the pharmaceutical industry is also inseparable from cooperation and integration. For the "old enterprise" of Jianfeng Group, the partners feel the same: the pattern is very large. In 2007
Kang Litao, general manager of Shanghai North Carolina Pharmaceutical, said that after joining Jianfeng Group, he deeply felt that although this is an old listed company restructured by a state-owned enterprise, the degree of standardization, marketization, and modernization is very high. The position of the helmsman is high, especially the high-tech talents are highly respected.
# Wang Yiyan, deputy manager of 104 daye peak manufacturing department, is a local and entered the enterprise in 2007
years in a row. Although some people often want to pay them a high salary, they all say with one voice: "I just want to be a peak worker." , as a high-tech peak pharmaceutical sector, has gathered a group of high-tech talents. The peak meets the needs of talents to "build a nest and attract the phoenix". Where the talents are, the R & D institutions will be established. It has attracted a large number of industry leaders and "returnees" talents, and promoted the innovation and development of new products and drugs.
Some people say that corporate culture is the boss culture. Jiang Xiaomeng started as a worker in Jianfeng Group, but he is also a recognized expert entrepreneur; as the chairman of a listed company, he is observing the general trend and seeking great things, but he has no airs in front of the employees, long-distance business trips, and the driver is tired on the way., He will drive by himself and let the driver take a rest in the passenger seat. He once said that the invisible road lies in seizing the opportunity. The impermanent law lies in taking advantage of the situation. Great skill selflessness lies in uniting people's hearts.
60 is a group of peak people with similar values and a unique peak culture leading the growth of the workforce. Over the years, Jianfeng Group has continuously integrated resources and added more and more new employees. Next, in the face of the complicated economic situation and fully competitive industry pattern, the adjustment of industrial structure will be increased, the integration and improvement of M & A enterprises need to be accelerated, and the training and upgrading of talents will be accelerated. It is necessary to require the peak to be in addition to the values of "being brave to open up, keeping pace with the times, and climbing the peak forever, integrate into the corporate culture of" innovation, tolerance, honesty and responsibility.
Management: Standardization and Science
If "Cooperation and Innovation to Strengthen the Main Business" emphasizes openness and inclusiveness, "Standardization and Science for Development" emphasizes management.
OA management system, financial management system, human resource management system, video conference system, etc. covering all enterprises of the group company, it realizes convenient management of cross-regional development while improving daily work efficiency. In addition, we will continue to carry out fine management. Through
on-site management of lean production, benchmarking management and comprehensive budget management, we will institutionalize and proceduralize them and become the daily management procedures and work habits of employees. Establish an assessment and evaluation system for managers at all levels, use the evaluation system to stimulate the motivation of managers, restrict the behavior of managers, and continue to promote the development of enterprise management to a high level and high efficiency. In order to promote the optimization of enterprise organization and post optimization, Jianfeng Group introduced the "amoeba" management concept in 2016
However, Jiang Xiaomeng said that as an enterprise manager, one must have a clear mind. Today's success does not mean eternal success in the future. Past glory does not mean eternal glory in the future. The management of a successful enterprise is always on the road. "We still have a lot to improve, improve and reform. For example, we still have a gap with advanced companies in terms of the quality and speed of innovative research and development, and we still have a lot to do in terms of lean production, technological innovation, cost control and seeking connotative growth." He said, "In the future, while doing a good business, we will pay more attention to social responsibility. Our goal is to be a century-old enterprise, a respected enterprise, so we will never be satisfied."
More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page